Qiu-Yue Lin Selected Research

Anaphase-Promoting Complex-Cyclosome

1/2018

CDC20 regulates cardiac hypertrophy via targeting LC3-dependent autophagy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qiu-Yue Lin Research Topics

Disease

7	Fibrosis (Cirrhosis) 02/2022 - 01/2018
7	Inflammation (Inflammations) 01/2022 - 01/2018
7	Hypertrophy 01/2022 - 01/2018
6	Cardiomegaly (Heart Hypertrophy) 01/2021 - 01/2018
5	Hypertension (High Blood Pressure) 01/2022 - 01/2018
3	Heart Diseases (Heart Disease) 02/2022 - 12/2019
3	Heart Failure 01/2022 - 06/2019
3	Atherosclerosis 01/2022 - 12/2019
2	Cardiac Edema 01/2022 - 01/2021
2	Hypertensive Retinopathy 01/2020 - 01/2018
2	Cardiovascular Diseases (Cardiovascular Disease) 12/2019 - 01/2018
2	Neoplasms (Cancer) 01/2014 - 06/2013
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 02/2022
1	Vascular Remodeling 01/2022
1	Edema (Dropsy) 01/2022
1	Alcoholism (Alcohol Abuse) 01/2020
1	Myocardial Infarction 12/2019
1	Reperfusion Injury 12/2019
1	Autoimmune Diseases (Autoimmune Disease) 06/2019
1	Atrial Remodeling 01/2019
1	Atrial Fibrillation 01/2019
1	Vascular System Injuries 01/2018
1	Carcinogenesis 01/2018
1	Hepatocellular Carcinoma (Hepatoma) 09/2012

Drug/Important Bio-Agent (IBA)

6	Angiotensin IIIBA 01/2022 - 01/2018
3	Proteasome Endopeptidase Complex (Proteasome)IBA 02/2022 - 01/2018
3	Superoxides (Superoxide)IBA 02/2022 - 01/2018
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 01/2018
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2018
2	ApolipoproteinsIBA 01/2022 - 01/2020
2	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 01/2022 - 01/2021
2	CytokinesIBA 01/2021 - 06/2019
2	Connexin 43 (Connexin43)IBA 01/2021 - 01/2019
2	Neutralizing AntibodiesIBA 01/2020 - 01/2018
2	Immunoglobulin G (IgG)IBA 01/2020 - 01/2018
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2020 - 12/2019
2	ResveratrolIBA 12/2019 - 01/2019
2	Pharmaceutical PreparationsIBA 01/2014 - 06/2013
1	Therapeutic UsesIBA 02/2022
1	epoxomicinIBA 01/2022
1	cadherin 5IBA 01/2022
1	AngiotensinsIBA 01/2022
1	Gallic AcidIBA 01/2022
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2022
1	p38 Mitogen-Activated Protein KinasesIBA 01/2022
1	Proteasome InhibitorsIBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Endoplasmic Reticulum Chaperone BiPIBA 01/2021
1	Vascular Endothelial Growth Factor CIBA 01/2021
1	CalcineurinIBA 01/2021
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2020
1	CholesterolIBA 01/2020
1	Apolipoproteins E (ApoE)IBA 01/2020
1	oxidized low density lipoproteinIBA 01/2020
1	c-Mer Tyrosine KinaseIBA 01/2020
1	Chymotrypsin FDA Link 01/2020
1	Immunoglobulins (Immunoglobulin)IBA 12/2019
1	Rituximab (Mabthera)FDA Link 06/2019
1	AntibodiesIBA 06/2019
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2019
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2019
1	VO-OHpicIBA 01/2019
1	ChemokinesIBA 01/2018
1	Chemokine ReceptorsIBA 01/2018
1	Interleukin-8B ReceptorsIBA 01/2018
1	TrypsinIBA 01/2018
1	Retinaldehyde (Retinal)IBA 01/2018
1	Chemokine CXCL1IBA 01/2018
1	N- (3,5- bis(trifluoromethyl)phenyl)- 5- chloro- 2- hydroxybenzamideIBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	Anaphase-Promoting Complex-CyclosomeIBA 01/2018
1	CopperIBA 09/2012